Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001562180-25-001917
Filing Date
2025-03-03
Accepted
2025-03-03 21:27:07
Documents
2
Period of Report
2025-03-03

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primarydocument.html 4/A  
1 PRIMARY DOCUMENT primarydocument.xml 4/A 6431
2 EX-24 POA - URI WEINBERG poa-ex24_weinberg.txt EX-24 4780
  Complete submission text file 0001562180-25-001917.txt   12799
Mailing Address NO. 4 THE FORUM GRENVILLE STREET ST. HELIER Y9 JE2 4UF
Business Address NO. 4 THE FORUM GRENVILLE STREET ST. HELIER Y9 JE2 4UF 44 (0)15 3475 6700
NovoCure Ltd (Issuer) CIK: 0001645113 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)

Mailing Address NOVOCURE INC., 20 VALLEY STREAM PARKWAY SUITE 300 MALVERN PA 19355
Business Address
Weinberg Uri (Reporting) CIK: 0001811030 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-37565 | Film No.: 25701196